A molecule engineered more than 20 years ago to reduce cholesterol levels now shows promise as a treatment for multiple sclerosis. The disease causes the body's immune system to attack the myelin sheath surrounding nerves, but experiments with mice show the sobetirome molecule -- recently modified so it can pass the blood-brain barrier -- acts to restore the myelin.
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.